BCG vaccine may help reduce risk of eczema in high-risk infants: study

Bacille Calmette-Guérin (BCG) vaccine could play a role in counteracting the rising prevalence of atopic diseases, say Melbourne clinicians who have been investigating whether neonatal BCG vaccination reduces the incidence of eczema in infants. Paediatric infectious disease physicians involved in the Melbourne Infant Study BCG for allergy and infection say a single dose of the vaccine ...

Already a member?

Login to keep reading.

© 2021 the limbic